These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16678216)

  • 1. Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.
    Hogg S; Michan L; Jessa M
    Neuropharmacology; 2006 Jul; 51(1):141-5. PubMed ID: 16678216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA
    Frias AT; Fernandes GG; Zangrossi H
    Behav Brain Res; 2019 May; 364():99-105. PubMed ID: 30768992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked innate defensive behaviours of the rat.
    Vargas LC; Schenberg LC
    Psychopharmacology (Berl); 2001 May; 155(3):260-8. PubMed ID: 11432688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
    de Bortoli VC; Nogueira RL; Zangrossi H
    Psychopharmacology (Berl); 2006 Jan; 183(4):422-8. PubMed ID: 16258751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic treatment normalizes midbrain dopaminergic neuron increase after periaqueductal gray stimulation.
    Tan SZK; Temel Y; Chan AY; Mok ATC; Perucho JAU; Blokland A; Aquili L; Lim WL; Lim LW
    Brain Struct Funct; 2020 Sep; 225(7):1957-1966. PubMed ID: 32594260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats.
    Jenck F; Moreau JL; Berendsen HH; Boes M; Broekkamp CL; Martin JR; Wichmann J; Van Delft AM
    Eur Neuropsychopharmacol; 1998 Aug; 8(3):161-8. PubMed ID: 9716307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine.
    Zanoveli JM; Pobbe RL; de Bortoli VC; Carvalho MC; Brandão ML; Zangrossi H
    Int J Neuropsychopharmacol; 2010 Sep; 13(8):1079-88. PubMed ID: 19941697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The panicolytic-like effect of fluoxetine in the elevated T-maze is mediated by serotonin-induced activation of endogenous opioids in the dorsal periaqueductal grey.
    Roncon CM; Biesdorf C; Santana RG; Zangrossi H; Graeff FG; Audi EA
    J Psychopharmacol; 2012 Apr; 26(4):525-31. PubMed ID: 22279131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5-HT
    Vilela-Costa HH; Maraschin JC; Casarotto PC; Sant'Ana AB; de Bortoli VC; Vicente MA; Campos AC; Guimarães FS; Zangrossi H
    Behav Brain Res; 2021 Apr; 404():113159. PubMed ID: 33571572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT (2A) receptors in the rat dorsal periaqueductal gray.
    de Bortoli VC; Nogueira RL; Zangrossi H
    Psychopharmacology (Berl); 2008 Jun; 198(3):341-9. PubMed ID: 18446327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
    Sánchez C; Meier E
    Psychopharmacology (Berl); 1997 Feb; 129(3):197-205. PubMed ID: 9084057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methimazole-induced hypothyroidism inhibits the panic-like behaviors produced by electrical stimulation of dorsal periaqueductal gray matter of rats.
    Siqueira CC; Rossoni RR; Tiengo AN; Tufik S; Schenberg LC
    Psychoneuroendocrinology; 2010 Jun; 35(5):706-16. PubMed ID: 19931985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze.
    Sela VR; Biesdorf C; Ramos DH; Zangrossi H; Graeff FG; Audi EA
    Neurosci Lett; 2011 May; 495(1):63-6. PubMed ID: 21421022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups.
    Fish EW; Faccidomo S; Gupta S; Miczek KA
    J Pharmacol Exp Ther; 2004 Feb; 308(2):474-80. PubMed ID: 14593091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats.
    Lim LW; Blokland A; van Duinen M; Visser-Vandewalle V; Tan S; Vlamings R; Janssen M; Jahanshahi A; Aziz-Mohammadi M; Steinbusch HW; Schruers K; Temel Y
    Behav Brain Res; 2011 Apr; 218(2):301-7. PubMed ID: 21185871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.